The revenue of 10x Genomics, Inc. over the past 9 years
Chart 10x Genomics, Inc.: revenue, fiscal 2017–2025 Open the chart →10x Genomics, Inc. reported revenue of $642.82M in fiscal 2025, the latest fiscal year on file. In fiscal 2017 it was $71.08M — up 804% over 8 years. Year over year, revenue rose 7 times and fell once. The largest one-year move was in fiscal 2018: up 106%, from $71.08M to $146.31M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $642.82M |
| 2024ended Dec 31, 2024 | $610.78M |
| 2023ended Dec 31, 2023 | $618.73M |
| 2022ended Dec 31, 2022 | $516.41M |
| 2021ended Dec 31, 2021 | $490.49M |
| 2020ended Dec 31, 2020 | $298.85M |
| 2019ended Dec 31, 2019 | $245.89M |
| 2018ended Dec 31, 2018 | $146.31M |
| 2017ended Dec 31, 2017 | $71.08M |
Fiscal years as 10x Genomics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on 10x Genomics, Inc.
- The profitability of 10x Genomics, Inc.
- The cash flow of 10x Genomics, Inc.
- The debt of 10x Genomics, Inc.
- All of 10x Genomics, Inc.'s financials, charted
Companies of a similar size
- HNGEHinge Health, Inc.
- DRSLeonardo DRS, Inc.
- HLHECLA MINING CO/DE/
- PBFPBF ENERGY INC.
- BAHBooz Allen Hamilton Holding Corporation
Not investment advice. This page shows what 10x Genomics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.